Matteo Carrabba

Author PubWeight™ 7.61^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findings.	J Clin Oncol	2002	2.57
2	Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction.	Immunol Rev	2002	1.66
3	Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of melanoma- and colon carcinoma-specific T cells.	J Immunol	2003	1.06
4	Reduced-intensity conditioning containing low-dose alemtuzumab before allogeneic peripheral blood stem cell transplantation: graft-versus-host disease is decreased but T-cell reconstitution is delayed.	Exp Hematol	2005	0.89
5	Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide.	Cancer Immunol Immunother	2007	0.85
6	CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.	Exp Hematol	2006	0.81